WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008099492) PYRIMIDINE NUCLEOSIDE DERIVATIVE AND SALT THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/099492    International Application No.:    PCT/JP2007/052758
Publication Date: 21.08.2008 International Filing Date: 15.02.2007
IPC:
C07H 19/09 (2006.01), A61K 31/7072 (2006.01), A61P 31/12 (2006.01)
Applicants: aRigen Pharmaceuticals, Inc. [JP/JP]; 3-37, Akasaka 7-chome Minato-ku, Tokyo 1070052 (JP) (For All Designated States Except US).
MACHIDA, Haruhiko [JP/JP]; (JP) (For US Only).
YAMAMOTO, Masaichi [JP/JP]; (JP) (For US Only)
Inventors: MACHIDA, Haruhiko; (JP).
YAMAMOTO, Masaichi; (JP)
Agent: SHAMOTO, Ichio; YUASA AND HARA, Section 206 New Ohtemachi Bldg. 2-1, Ohtemachi 2-chome Chiyoda-ku, Tokyo 1000004 (JP)
Priority Data:
Title (EN) PYRIMIDINE NUCLEOSIDE DERIVATIVE AND SALT THEREOF
(FR) DÉRIVÉ DE PYRIMIDINE NUCLÉOSIDE ET SON SEL
(JA) ピリミジンヌクレオシド誘導体及びその塩
Abstract: front page image
(EN)A novel pyrimidine nucleoside derivative represented by the following formula (1) and a salt thereof. Also provided is a medicinal composition containing the derivative or salt as an active ingredient. The composition has excellent antiviral properties and is useful as an antiviral agent. [In the formula, R represents a nitrogenous heterocycle optionally having as a substituent any one of C1-3 alkyls and C1-3 alkoxys or represents C1-6 alkyl having one primary amino group as a substituent.]
(FR)L'invention porte sur un nouveau dérivé de pyrimidine nucléoside représenté par la formule (1) suivante et sur un sel de ce dérivé. L'invention porte également sur une composition médicamenteuse contenant le dérivé ou sel comme principe actif. La composition présente d'excellentes propriétés antivirales et est utile comme agent antiviral. [Dans la formule, R représente un hétérocycle azoté ayant facultativement comme substituant n'importe lequel parmi alkyle en C1-3 et alcoxy en C1-3 ou représente un alkyle en C1-6 ayant un groupe amino primaire comme substituant.]
(JA) 下記式(1)で表される新規ピリミジンヌクレオシド誘導体及びその塩、並びにこれを有効成分とする医薬組成物は、優れた抗ウイルス特性を有し、抗ウイルス治療剤として有用である。 [式中Rは、置換基として炭素数1~3のアルキル基、又は炭素数1~3のアルコキシ基のうちいずれかを1個有してもよい含窒素複素環、又は一級アミノ基を置換基として1個有する炭素数1~6個のアルキル基を示す]                                                                               
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)